Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4222279 | 0.88 | EP300 (0.43) | EP300 | |
| Trifluoroacetic Acid SCHEMBL4227766 | 0.81 | MTTP (0.43) | EP300 | |
| Trifluoroacetic Acid SCHEMBL4227412 | 0.80 | HCRTR1 (0.45) | EP300 | |
| Trifluoroacetic Acid SCHEMBL4232750 | 0.78 | ALDH1A1 (0.43) | EP300 | |
| Trifluoroacetic Acid SCHEMBL4228165 | 0.73 | IRAK4 (0.41) | EP300 | |
| SCHEMBL1709554 | 0.73 | EP300 (0.53) | EP300CREBBP | |
| Hydrochloric Acid SCHEMBL933356 | 0.72 | EP300 (0.52) | EP300CREBBP | |
| Trifluoroacetic Acid SCHEMBL3607735 | 0.71 | HCAR3 (0.43) | — | |
| SCHEMBL4237398 | 0.69 | ABCB1 (0.42) | EP300 | |
| Trifluoroacetic Acid SCHEMBL3603250 | 0.69 | DPP7 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2096104-A1 | Organic diamines as mGluR7 modulators | Novartis AG (CH) | 2009-09-02 | — | — | EP | disclosed |
| US-20080242698-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242698-A1 | Organic Compounds | AOC1, OTC, ODC1 | EP300 1884/4885CREBBP 2957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.